Adamis Pharmaceuticals Corp (ADMP) Down 2.94% in Premarket Trading

Wednesday, August 09, 2023 07:26 AM | InvestorsObserver Analysts

Mentioned in this article

Adamis Pharmaceuticals Corp (ADMP) has fallen Wednesday morning, with the stock declining -2.94% in pre-market trading to 1.32. ADMP's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 140 out of 146 industries, ADMP ranks higher than 0% of stocks. Adamis Pharmaceuticals Corp has fallen 36.74% over the past month, closing at $2.30 on July 12. During this period of time, the stock fell as low as $1.33 and as high as $8.28.

ADMP has an Overall Score of 7. Find out what this means to you and get the rest of the rankings on ADMP!
Adamis Pharmaceuticals Corp has a Long-Term Technical rank of 20. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 80% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 134 by this metric, ADMP ranks better than 134% of stocks.

Important Dates for Investors in ADMP:

-Adamis Pharmaceuticals Corp is set to release earnings on 11/7/2023. Over the last 12 months, the company has reported EPS of $-0.05. -We do not have a set dividend date for Adamis Pharmaceuticals Corp at this time. Click Here To Get The Full Report on Adamis Pharmaceuticals Corp (ADMP)

Share this article: